{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:06:11Z","timestamp":1787313971237,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC112-2320-B-006-005"],"award-info":[{"award-number":["NSTC112-2320-B-006-005"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2320-B-006-015-MY3"],"award-info":[{"award-number":["NSTC 112-2320-B-006-015-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004844","name":"National Cheng Kung University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007750","name":"National Cheng Kung University","doi-asserted-by":"publisher","award":["D112-F2510"],"award-info":[{"award-number":["D112-F2510"]}],"id":[{"id":"10.13039\/501100007750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012537","name":"Ditmanson Medical Foundation Chia-Yi Christian Hospital","doi-asserted-by":"publisher","award":["CYC109008"],"award-info":[{"award-number":["CYC109008"]}],"id":[{"id":"10.13039\/501100012537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.lfs.2024.123255","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T11:43:58Z","timestamp":1731757438000},"page":"123255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Decrease of KATP channel expression through D3 receptor-mediated GSK3\u03b2 signaling alleviates levodopa-induced dyskinesia (LID) in Parkinson's disease mouse model"],"prefix":"10.1016","volume":"359","author":[{"given":"Yi-Ying","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sih-Yu","family":"Pen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Chen","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Hsuan","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Han","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Bing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2024.123255_bb0005","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of Parkinson\u2019s disease","volume":"139","author":"Sveinbjornsdottir","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2024.123255_bb0010","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.lfs.2024.123255_bb0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(77)91146-1","article-title":"Success and problems of long-term levodopa therapy in Parkinson's disease","volume":"1","author":"Marsden","year":"1977","journal-title":"Lancet (London, England)."},{"key":"10.1016\/j.lfs.2024.123255_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2011.00051","article-title":"Striatal signaling in L-DOPA-induced dyskinesia: common mechanisms with drug abuse and Long term memory involving D1 dopamine receptor stimulation","volume":"5","author":"Murer","year":"2011","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.lfs.2024.123255_bb0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mds.10031","article-title":"Clinical-pathological study of levodopa complications","volume":"17","author":"Rajput","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.lfs.2024.123255_bb0030","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/pgmj.2006.054759","article-title":"Levodopa-induced dyskinesia in Parkinson\u2019s disease: clinical features, pathogenesis, prevention and treatment","volume":"83","author":"Thanvi","year":"2007","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.lfs.2024.123255_bb0035","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/aian.AIAN_239_17","article-title":"Levodopa-induced dyskinesia: clinical features, pathophysiology, and medical management","volume":"20","author":"Pandey","year":"2017","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.lfs.2024.123255_bb0040","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/mds.26955","article-title":"Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice","volume":"32","author":"Perez","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.lfs.2024.123255_bb0045","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.neuron.2018.01.017","article-title":"A subpopulation of striatal neurons mediates levodopa-induced dyskinesia","volume":"97","author":"Girasole","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.lfs.2024.123255_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bph.12906","article-title":"Dopamine receptors - IUPHAR review 13","volume":"172","author":"Beaulieu","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123255_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105263","article-title":"D2R signaling in striatal spiny neurons modulates L-DOPA induced dyskinesia","volume":"25","author":"Florio","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.lfs.2024.123255_bb0060","first-page":"435","article-title":"Dopamine D3 receptor modulates l-DOPA-induced dyskinesia by targeting D1 receptor-mediated striatal signaling","volume":"27","author":"Solis","year":"2017","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.lfs.2024.123255_bb0065","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35075076","article-title":"BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization","volume":"411","author":"Guillin","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2024.123255_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9030314","article-title":"Dopamine D3 receptor plasticity in Parkinson\u2019s disease and L-DOPA-induced dyskinesia","volume":"9","author":"Lanza","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.lfs.2024.123255_bb0075","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1523\/JNEUROSCI.11-12-03727.1991","article-title":"D2 dopamine receptor activation of potassium channels in identified rat lactotrophs: whole-cell and single-channel recording","volume":"11","author":"Einhorn","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2024.123255_bb0080","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1152\/jn.00254.2006","article-title":"Dopamine D(2) receptor modulation of K(+) channel activity regulates excitability of nucleus accumbens neurons at different membrane potentials","volume":"96","author":"Perez","year":"2006","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.lfs.2024.123255_bb0085","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1085\/jgp.115.6.697","article-title":"Dominant-negative mutants identify a role for GIRK channels in D3 dopamine receptor-mediated regulation of spontaneous secretory activity","volume":"115","author":"Kuzhikandathil","year":"2000","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.lfs.2024.123255_bb0090","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1006\/mcne.1998.0722","article-title":"Human dopamine D3 and D2L receptors couple to inward rectifier potassium channels in mammalian cell lines","volume":"12","author":"Kuzhikandathil","year":"1998","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.lfs.2024.123255_bb0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00582512","article-title":"Adenosine-5\u2032-triphosphate-sensitive ion channels in neonatal rat cultured central neurones","volume":"412","author":"Ashford","year":"1988","journal-title":"Arch. Eur. J. Physiol."},{"key":"10.1016\/j.lfs.2024.123255_bb0100","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00585961","article-title":"Identification of an ATP-sensitive K+ channel in spiny neurons of rat caudate nucleus","volume":"427","author":"Schwanstecher","year":"1994","journal-title":"Arch. Eur. J. Physiol."},{"key":"10.1016\/j.lfs.2024.123255_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(96)01006-2","article-title":"Low-affinity sulfonylurea binding sites reside on neuronal cell bodies in the brain","volume":"745","author":"Dunn-Meynell","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2024.123255_bb0110","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0896-6273(00)80321-9","article-title":"Association and stoichiometry of KATP Channel subunits","volume":"18","author":"Clement","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.lfs.2024.123255_bb0115","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/nn.3185","article-title":"K-ATP channels in dopamine substantia nigra neurons control bursting and novelty-induced exploration","volume":"15","author":"Schiemann","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.lfs.2024.123255_bb0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.bjp.0701120","article-title":"KATP-channel on the somata of spiny neurones in rat caudate nucleus: regulation by drugs and nucleotides","volume":"121","author":"Schwanstecher","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123255_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106452","article-title":"Suppression of presynaptic corticostriatal glutamate activity attenuates L-dopa-induced dyskinesia in 6-OHDA-lesioned Parkinson\u2019s disease mice","volume":"193","author":"Huang","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.lfs.2024.123255_bb0130","doi-asserted-by":"crossref","first-page":"174","DOI":"10.5607\/en.2016.25.4.174","article-title":"Palmitoyl serotonin inhibits L-dopa-induced abnormal involuntary movements in the mouse Parkinson model","volume":"25","author":"Park","year":"2016","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.lfs.2024.123255_bb0135","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.nbd.2016.09.001","article-title":"Validation of an improved scale for rating l-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists","volume":"96","author":"Sebastianutto","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.lfs.2024.123255_bb0140","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.11856","article-title":"beta-Lapachone ameliorates L-DOPA-induced dyskinesia in a 6-OHDA-induced mouse model of Parkinson\u2019s disease","volume":"23","author":"Ryu","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2024.123255_bb0145","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1523\/JNEUROSCI.0267-20.2020","article-title":"Abnormal Cortico-basal ganglia neurotransmission in a mouse model of l-DOPA-induced dyskinesia","volume":"41","author":"Dwi Wahyu","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2024.123255_bb0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jnutbio.2018.05.005","article-title":"Chronic palmitic acid-induced lipotoxicity correlates with defective trafficking of ATP sensitive potassium channels in pancreatic beta cells","volume":"59","author":"Ruan","year":"2018","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.lfs.2024.123255_bb0155","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.lfs.2024.123255_bb0160","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12929-019-0613-y","article-title":"Dopamine D(3) receptor and GSK3beta signaling mediate deficits in novel object recognition memory within dopamine transporter knockdown mice","volume":"27","author":"Chang","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.lfs.2024.123255_bb0165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.phrs.2015.03.010","article-title":"Glycogen synthase kinase-3 beta (GSK-3beta) signaling: implications for Parkinson\u2019s disease","volume":"97","author":"Golpich","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2024.123255_bb0170","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/jnc.15794","article-title":"Endonuclease VIII-like 1 deficiency potentiates nigrostriatal dopaminergic neuron degeneration in a male mouse model of Parkinson\u2019s disease","volume":"165","author":"Chen","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2024.123255_bb0175","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0301-0082(96)00040-8","article-title":"The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments","volume":"50","author":"Schwarting","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.lfs.2024.123255_bb0180","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.nbd.2008.11.010","article-title":"Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson\u2019s disease","volume":"35","author":"Visanji","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.lfs.2024.123255_bb0185","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1152\/jn.00254.2006","article-title":"Dopamine D2 receptor modulation of K+ channel activity regulates excitability of nucleus Accumbens neurons at different membrane potentials","volume":"96","author":"Perez","year":"2006","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.lfs.2024.123255_bb0190","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tips.2007.02.006","article-title":"The Akt-GSK-3 signaling cascade in the actions of dopamine","volume":"28","author":"Beaulieu","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2024.123255_bb0195","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/nn1570","article-title":"K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons","volume":"8","author":"Liss","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.lfs.2024.123255_bb0200","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1096\/fj.04-1551fje","article-title":"Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death","volume":"18","author":"Chen","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2024.123255_bb0205","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fnmol.2020.00081","article-title":"GSK-3beta contributes to parkinsonian dopaminergic neuron death: evidence from conditional knockout mice and tideglusib","volume":"13","author":"Li","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.lfs.2024.123255_bb0210","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/cn300182g","article-title":"Glycogen synthase kinase-3 inhibitors as potent therapeutic agents for the treatment of Parkinson disease","volume":"4","author":"Morales-Garcia","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.lfs.2024.123255_bb0215","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/jnc.12206","article-title":"Transient and rapid activation of Akt\/GSK-3beta and mTORC1 signaling by D3 dopamine receptor stimulation in dorsal striatum and nucleus accumbens","volume":"125","author":"Salles","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2024.123255_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084413","article-title":"Glycogen synthase kinase 3: ion channels, plasticity, and diseases","volume":"23","author":"Marosi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123255_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112660","article-title":"Leptin-induced trafficking of KATP channels: a mechanism to regulate pancreatic beta-cell excitability and insulin secretion","volume":"20","author":"Cochrane","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123255_bb0230","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbrc.2013.09.099","article-title":"AMPK regulates K(ATP) channel trafficking via PTEN inhibition in leptin-treated pancreatic beta-cells","volume":"440","author":"Park","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2024.123255_bb0235","doi-asserted-by":"crossref","first-page":"9331","DOI":"10.1074\/jbc.M806774200","article-title":"Leptin-dependent phosphorylation of PTEN mediates actin restructuring and activation of ATP-sensitive K+ channels","volume":"284","author":"Ning","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2024.123255_bb0240","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.mcn.2018.08.006","article-title":"Deletion of Kir6.2\/SUR1 potassium channels rescues diminishing of DA neurons via decreasing iron accumulation in PD","volume":"92","author":"Zhang","year":"2018","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.lfs.2024.123255_bb0245","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13618","article-title":"Role of upregulation of the K(ATP) channel subunit SUR1 in dopaminergic neuron degeneration in Parkinson\u2019s disease","volume":"21","author":"Liu","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.lfs.2024.123255_bb0250","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/jnr.20467","article-title":"Systematic administration of iptakalim, an ATP-sensitive potassium channel opener, prevents rotenone-induced motor and neurochemical alterations in rats","volume":"80","author":"Yang","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.lfs.2024.123255_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2021.05.008","article-title":"Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson\u2019s disease model","volume":"349","author":"Qiu","year":"2021","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.lfs.2024.123255_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118070","article-title":"The role of K(ATP) channel blockade and activation in the protection against neurodegeneration in the rotenone model of Parkinson's disease","volume":"257","author":"Abdelkader","year":"2020","journal-title":"Life Sci."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524008452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524008452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T07:07:07Z","timestamp":1738134427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524008452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":52,"alternative-id":["S0024320524008452"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123255","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decrease of KATP channel expression through D3 receptor-mediated GSK3\u03b2 signaling alleviates levodopa-induced dyskinesia (LID) in Parkinson's disease mouse model","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123255"}}